What is NDC 59651-429?

59651-429 is the product NDC for Potassium Chloride, Potassium chloride 750 mg/1 tablet, extended release, listed with the FDA by Aurobindo Pharma Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Potassium Chloride?

218 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Potassium Chloride NDC 59651-429 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-429Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0429Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
59651-429-01	59651042901	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-429-01)Marketed from Mar 31, 2021
59651-429-90	59651042990	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-429-90)Marketed from Mar 31, 2021
59651-429-99	59651042999	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-429-99)Marketed from Mar 31, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Chloride
Generic name (nonproprietary): potassium chloride
Active ingredients: Potassium chloride — 750 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214728
Marketing start: Mar 31, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
Identifiers: Product ID 59651-429_d1038d80-ef7d-456a-9f47-0c5df1ca8811SPL ID d1038d80-ef7d-456a-9f47-0c5df1ca8811SPL set ID deb6b462-397f-4527-ae26-40dc5d5857bcRxCUI 403888, 1801294, 1801298UNII 660YQ98I10
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651042901 followed by a unit qualifier and the quantity

Package 59651-0429-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 30, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication, and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59651-429

What is NDC 59651-429?: 59651-429 is the product NDC for Potassium Chloride, Potassium chloride 750 mg/1 tablet, extended release, listed with the FDA by Aurobindo Pharma Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Potassium Chloride.
What is the active ingredient?: Potassium chloride.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Potassium Chloride?: 218 other product NDCs are listed under this name. See all Potassium Chloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Potassium Chloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Potassium Chloridepotassium chloride oral	Potassium chloride 1.5 g/15mL	SolutionOral	Cardinal Health 107, LLC	55154-8026	55154-8026-05
Potassium Chloride	Potassium chloride 1.5 g/1.58g	Powder, For solutionOral	Cardinal Health 107, LLC	55154-8352	55154-8352-05
Potassium Chloride	Potassium chloride 750 mg/1	Tablet, Film coated, Extended releaseOral	Coupler LLC	67046-1032	67046-1032-03
Potassium Chloride	Potassium chloride 750 mg/1	Tablet, Film coated, Extended releaseOral	St. Mary's Medical Park Pharmacy	60760-423	60760-0423-90
Potassium Chloride	Potassium chloride 750 mg/1	Tablet, Extended releaseOral	Northwind Health Company, LLC	82868-111	82868-0111-90
Potassium Chloride	Potassium chloride 20 meq/15mL	SolutionOral	Ajenat Pharmaceuticals LLC	82983-411	82983-0411-47
Potassium Chloride	Potassium chloride 40 meq/15mL	SolutionOral	Ajenat Pharmaceuticals LLC	82983-412	82983-0412-47
Potassium Chloride	Potassium chloride 20 meq/1	Tablet, Extended releaseOral	Major Pharmaceuticals	0904-7548	00904-7548-61
Potassium Chloride	Potassium chloride 3 g/3.16g	For solutionOral	IPG Pharmaceuticals, Inc.	71085-083	71085-0083-30
Potassium Chloride	Potassium chloride 40 meq/15mL	SolutionOral	Aurobindo Pharma Limited	59651-960	59651-0960-47

All 219 Potassium Chloride NDCs

Other NDCs under ANDA 214728

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214728
Product	Strength	Form · route	Labeler	Product NDC
Potassium Chloride	Potassium chloride 1125 mg/1	Tablet, Extended releaseOral	Aurobindo Pharma Limited	59651-430
Potassium Chloride	Potassium chloride 1500 mg/1	Tablet, Extended releaseOral	Aurobindo Pharma Limited	59651-431